Etibliss ES 0.5mg/10mg Tablet
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Etizolam (0.5mg) + Escitalopram Oxalate (10mg)
Overview Etibliss ES 0.5mg/10mg Tablet
Deprenix 0.5mg/10mg tablets, a prescription medication, manage depressive symptoms. This dual-action formulation reduces excessive neuronal activity, calming the brain, while simultaneously boosting mood-regulating neurotransmitters. Deprenix may be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your physician's prescribed dosage and duration; habit formation is possible. Missed doses should be taken promptly upon recall. Complete the entire course, even with improvement. Abrupt cessation can trigger withdrawal; discontinue only under medical supervision. Common side effects include nausea, vomiting, diarrhea, cognitive impairment (confusion, memory issues), reduced libido, delayed ejaculation, dizziness, and somnolence. Avoid activities demanding alertness (like driving) until the drug's effects are known. Report any unusual mood shifts immediately, including suicidal ideation, to your doctor. Weight gain is a possibility; maintain a healthy diet and exercise routine. Caution is advised for individuals with liver impairment. Disclose all other medications to your doctor, as interactions can affect efficacy or alter the drug's action. Notify your doctor of pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Etibliss ES 0.5mg/10mg Tablet
No text provided to rephrase.
Uses of Etibliss ES 0.5mg/10mg Tablet
Clinical depression
Major Benefits of Etibliss ES 0.5mg/10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Etibliss ES 0.5mg/10mg Tablet whole; avoid chewing, crushing, or breaking it. While you can consume it with or without food, consistent timing is recommended.
Common Side effects of Etibliss ES 0.5mg/10mg Tablet:
- Delayed ejaculation
- Confusion
- Vomiting
- Memory impairment
- Drowsiness
- Tiredness
- Anorgasmia (decreased orgasm)
- Low sexual desire
- Nausea
- Diarrhea
- Uncoordinated body movements
How to use Etibliss ES 0.5mg/10mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the Etibliss ES 0.5mg/10mg Tablet whole; avoid chewing, crushing, or fracturing. Consumption may coincide with meals or be taken independently; however, consistent daily timing is recommended.
How Etibliss ES 0.5mg/10mg Tablet works:
Each Etibliss ES tablet (0.5mg/10mg) contains a dual-drug formulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Etibliss ES 0.5mg/10mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Etibliss ES 0.5mg/10mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Etibliss ES 0.5mg/10mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Etibliss ES 0.5mg/10mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Etibliss ES 0.5mg/10mg Tablets cautiously, as dosage modification may be necessary. A physician's consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Etibliss ES 0.5mg/10mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Etibliss ES 0.5mg/10mg Tablet :
Should you forget to take your Etibliss ES 0.5mg/10mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Etibliss ES 0.5mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
3,018 People bought this recently